QQ客服 官方微博 反馈留言

	Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory
	Wu, Jiayuan[1]; Hu, Liren[2]; Zhang, Gaohua[2]; Liang, Qilian[3]; Meng, Qiong[4]; Wan, Chonghua[5]
刊名	QUALITY OF LIFE RESEARCH
	2016
卷号	25页码:2087-2100
关键词	Quality of life Nasopharyngeal cancer Generalizability theory Classical test theory Standardized response mean
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2195343
专题	华南理工大学
作者单位	1.[1]Guangdong Med Coll, Dept Nutr, Affiliated Hosp, Zhanjiang 524001, Guangdong, Peoples R China 2.[2]Guangdong Med Coll, Sch Pub Hlth, Zhanjiang 524023, Guangdong, Peoples R China 3.[3]Guangdong Med Coll, Dept Oncol, Affiliated Hosp, Zhanjiang 524001, Guangdong, Peoples R China 4.[4]Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Yunnan, Peoples R China 5.[5]Guangdong Med Coll, Res Ctr Qual Life & Appl Psychol, Sch Humanities & Management, Dongguan 523808, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Wu, Jiayuan[1],Hu, Liren[2],Zhang, Gaohua[2],et al. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory[J]. QUALITY OF LIFE RESEARCH,2016,25:2087-2100.
APA	Wu, Jiayuan[1],Hu, Liren[2],Zhang, Gaohua[2],Liang, Qilian[3],Meng, Qiong[4],&Wan, Chonghua[5].(2016).Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.QUALITY OF LIFE RESEARCH,25,2087-2100.
MLA	Wu, Jiayuan[1],et al."Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory".QUALITY OF LIFE RESEARCH 25(2016):2087-2100.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。